Investors Sell Shares of Johnson & Johnson (JNJ) on Strength (JNJ)
Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Tuesday. $91.84 million flowed into the stock on the tick-up and $188.35 million flowed out of the stock on the tick-down, for a money net flow of $96.51 million out of the stock. Of all companies tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $0.43 for the day and closed at $119.75
A number of equities analysts recently issued reports on JNJ shares. BTIG Research reissued a “neutral” rating on shares of Johnson & Johnson in a report on Thursday, August 25th. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $124.21 price objective on the stock in a report on Monday, August 22nd. Deutsche Bank AG reissued a “buy” rating and issued a $142.00 price objective on shares of Johnson & Johnson in a report on Friday, August 19th. Jefferies Group raised their price objective on shares of Johnson & Johnson from $113.00 to $119.00 and gave the stock a “hold” rating in a report on Thursday, August 4th. Finally, Goldman Sachs Group set a $121.00 price objective on shares of Johnson & Johnson and gave the stock a “neutral” rating in a report on Monday, June 13th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and twelve have given a buy rating to the company’s stock. Johnson & Johnson currently has an average rating of “Hold” and a consensus price target of $119.53.
The firm has a market cap of $327.62 billion and a P/E ratio of 22.32. The firm has a 50 day moving average of $122.32 and a 200 day moving average of $115.21.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/07/investors-sell-shares-of-johnson-johnson-jnj-on-strength-jnj.html
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, July 19th. The company reported $1.74 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.68 by $0.06. The business earned $18.50 billion during the quarter, compared to analyst estimates of $17.98 billion. On average, equities analysts forecast that Johnson & Johnson will post $6.69 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, August 19th. Investors of record on Friday, August 5th were issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.97%.
In other news, CAO Ronald A. Kapusta sold 2,935 shares of the firm’s stock in a transaction that occurred on Friday, July 22nd. The shares were sold at an average price of $125.01, for a total transaction of $366,904.35. Following the sale, the chief accounting officer now owns 28,660 shares of the company’s stock, valued at approximately $3,582,786.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Dominic J. Caruso sold 41,146 shares of the firm’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $125.01, for a total transaction of $5,143,661.46. Following the sale, the vice president now directly owns 157,819 shares in the company, valued at approximately $19,728,953.19. The disclosure for this sale can be found here.
Several large investors have recently modified their holdings of JNJ. American International Group Inc. boosted its stake in shares of Johnson & Johnson by 2.9% in the fourth quarter. American International Group Inc. now owns 1,543,576 shares of the company’s stock worth $158,556,000 after buying an additional 43,388 shares during the last quarter. Matarin Capital Management LLC purchased a new stake in shares of Johnson & Johnson during the fourth quarter worth approximately $5,275,000. Finally, Wafra Investment Advisory Group Inc. NY boosted its stake in shares of Johnson & Johnson by 10.0% in the fourth quarter. Wafra Investment Advisory Group Inc. NY now owns 22,608 shares of the company’s stock worth $2,322,000 after buying an additional 2,058 shares during the last quarter.
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.
Receive News & Ratings for Johnson & Johnson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Johnson & Johnson and related companies with MarketBeat.com’s FREE daily email newsletter.